What is Janler?
Established in 1952, Janler Corporation operates as a premier, family-owned provider of custom mold making and injection molding services. The company has carved out a robust market position by delivering precision-engineered solutions across critical sectors, including medical device manufacturing, food and beverage packaging, and consumer goods. With dual ISO 9001:2015 and ISO 13485 certifications, Janler distinguishes itself through a commitment to high-tolerance, multi-cavity mold production. By integrating advanced engineering design with comprehensive injection molding capabilities, the firm serves as a vital link in the domestic supply chain, supporting complex manufacturing requirements that demand both technical rigor and operational reliability.
How much funding has Janler raised?
Janler has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Janler
PPP
Public-Private Partnership
What's next for Janler?
With this late-stage funding secured, Janler is well-positioned to accelerate its strategic initiatives aimed at modernizing its manufacturing infrastructure and expanding its service capacity. The company is expected to leverage this financial backing to enhance its technological footprint, potentially investing in automated production systems and advanced material handling to meet the evolving demands of the medical and packaging industries. As the firm navigates the complexities of the current industrial climate, the focus will likely remain on maintaining its reputation for quality while scaling operations to support larger, more intricate client projects. This capital deployment serves as a catalyst for long-term sustainability, ensuring that Janler remains at the forefront of U.S. manufacturing excellence for the next generation of industrial innovation.
See full Janler company page